Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK
Authors Neal D. Shore, Ugo De Giorgi, and Stephen J. Freedland
Our Affiliates
The landscape of androgen deprivation therapies for the treatment of advanced...
Leave a Reply
Want to join the discussion?Feel free to contribute!